Company Profile

InKine Pharmaceutical Company Inc (AKA: Panax Pharmaceutical Company Ltd)
Profile last edited on: 5/25/2017      CAGE:       UEI:

Business Identifier: Diagnostics and therapeutics for gastrointestinal disorders and cancer
Year Founded
1993
First Award
2001
Latest Award
2001
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1787 Sentry Pkwy W Building 18 Suite 440
Blue Bell, PA 19422
   (215) 283-6850
   info@inkine.com
   www.inkine.com
Location: Single
Congr. District: 04
County: Montgomery

Public Profile

Formerly doing business as Panax Pharmaceutical Company Ltd, InKine Pharmaceutical Company Inc. began operations as an ethnobiologics firm organzied around development of drugs from traditional medicinal plants. After going public in 1995, the firm went through series of mergers and acqusitions to broaden the base of the firm's business operations and completed a series of post-IPO fund raising efforts before being itself acquired in 2005. Over the period the firm had shifted focus to diagnosis and treatment of cancer and autoimmune diseases. In Summer 2005, creating one of the largest US companies focused exclusively on gastroenterology, Salix Pharmaceuticals - itself an SBIR involved firm - acquired InKine Pharmaceutical in a tax-free stock swap.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : INKP
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2001 1 NIH $99,619
Project Title: Anti-Metastatic Effect of Thrombospond Derived Peptides

Key People / Management

  Leonard S Jacob -- Chief Exec. Officer

  Taffy Williams -- President and Founder

  George P Tuszynski

Company News

There are no news available.